Cargando…
Fluoroquinolone heteroresistance in Mycobacterium tuberculosis: detection by genotypic and phenotypic assays in experimentally mixed populations
Heteroresistance - the simultaneous presence of drug-susceptible and -resistant organisms - is common in Mycobacterium tuberculosis. In this study, we aimed to determine the limit of detection (LOD) of genotypic assays to detect gatifloxacin-resistant mutants in experimentally mixed populations. A f...
Autores principales: | Rigouts, L., Miotto, P., Schats, M., Lempens, P., Cabibbe, A. M., Galbiati, S., Lampasona, V., de Rijk, P., Cirillo, D. M., de Jong, B. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692311/ https://www.ncbi.nlm.nih.gov/pubmed/31409849 http://dx.doi.org/10.1038/s41598-019-48289-9 |
Ejemplares similares
-
Correlation of different phenotypic drug susceptibility testing methods for four fluoroquinolones in Mycobacterium tuberculosis
por: Coeck, Nele, et al.
Publicado: (2016) -
How Well Do Routine Molecular Diagnostics Detect Rifampin Heteroresistance in Mycobacterium tuberculosis?
por: Ng, Kamela C. S., et al.
Publicado: (2019) -
Fluoroquinolone heteroresistance, antimicrobial tolerance, and lethality enhancement
por: Singh, Amit, et al.
Publicado: (2022) -
Detection of Pyrazinamide Heteroresistance in Mycobacterium tuberculosis
por: Werngren, Jim, et al.
Publicado: (2021) -
Diagnostic Performance of the New Version (v2.0) of GenoType MTBDRsl Assay for Detection of Resistance to Fluoroquinolones and Second-Line Injectable Drugs: a Multicenter Study
por: Tagliani, Elisa, et al.
Publicado: (2015)